209224-98-6 Usage
Uses
Used in Pharmaceutical Industry:
2,3-Dihydro-1H-cyclopenta[a]naphthalene-2-carboxylic acid is used as a starting material for the synthesis of various pharmaceuticals and organic compounds. Its unique chemical structure and properties make it an important intermediate in organic synthesis and drug discovery research.
Used in Drug Development:
2,3-Dihydro-1H-cyclopenta[a]naphthalene-2-carboxylic acid is used as a potential candidate for drug development due to its potential anti-inflammatory and analgesic properties. It has been studied for its potential use in the treatment of various medical conditions, including arthritis and cancer.
Used in Organic Synthesis Research:
2,3-Dihydro-1H-cyclopenta[a]naphthalene-2-carboxylic acid is used as an important intermediate in organic synthesis research. Its unique chemical structure and properties make it a valuable compound for the development of new organic compounds and materials.
Check Digit Verification of cas no
The CAS Registry Mumber 209224-98-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,9,2,2 and 4 respectively; the second part has 2 digits, 9 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 209224-98:
(8*2)+(7*0)+(6*9)+(5*2)+(4*2)+(3*4)+(2*9)+(1*8)=126
126 % 10 = 6
So 209224-98-6 is a valid CAS Registry Number.
209224-98-6Relevant articles and documents
Design and synthesis of the potent, orally available, brain-penetrable arylpyrazole class of neuropeptide Y5 receptor antagonists
Sato, Nagaaki,Takahashi, Toshiyuki,Shibata, Takunobu,Haga, Yuji,Sakuraba, Aya,Hirose, Masaaki,Sato, Miki,Nonoshita, Katsumasa,Koike, Yuko,Kitazawa, Hidefumi,Fujino, Naoko,Ishii, Yasuyuki,Ishihara, Akane,Kanatani, Akio,Fukami, Takehiro
, p. 666 - 669 (2007/10/03)
Novel arylpyrazole derivatives were synthesized and evaluated as neuropeptide Y (NPY) Y5 receptor antagonists. Compound (-)-7, which features a novel chiral 2,3-dihydro-1H-cyclopenta [a] naphthalene moiety, showed good binding affinity and antagonistic ac
Pyrazole derivatives
-
, (2008/06/13)
The present invention relates to a compound represented by the general formula [I]: wherein A and B rings are ortho-condensed to each other, A ring represents an aromatic carbocyclic or heterocyclic ring and B ring represents an aliphatic four- to seven-m